HNF-1α and endodermal transcription factors cooperatively activate Fabpl: MODY3 mutations abrogate cooperativity

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 285, Issue 1 48-1, 2003, Pages

  Divine, Joyce K ^a   McCaul, Sean P ^a   Simon, Theodore C ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; FATTY ACID BINDING PROTEIN; HEPATOCYTE NUCLEAR FACTOR 3BETA; HEPATOCYTE NUCLEAR FACTOR 4; NUCLEAR FACTOR I; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CDX1; TRANSCRIPTION FACTOR GATA 4; UNCLASSIFIED DRUG; CARRIER PROTEIN; DNA BINDING PROTEIN; FABP5 PROTEIN, MOUSE; FABP7 PROTEIN, HUMAN; FABP7 PROTEIN, MOUSE; FABP7 PROTEIN, RAT; HEPATOCYTE NUCLEAR FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HEPATOCYTE NUCLEAR FACTOR 1BETA; NERVE PROTEIN; NUCLEAR PROTEIN; TCF1 PROTEIN, HUMAN; TCF1 PROTEIN, MOUSE; TCF1 PROTEIN, RAT; TCF2 PROTEIN, HUMAN; TCF2 PROTEIN, MOUSE; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CONTROLLED STUDY; ENDODERM; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; HUMAN CELL; LIVER; MATURITY ONSET DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; TRANSACTIVATION; TRANSGENE; ANIMAL; CELL STRAIN CACO 2; GENETIC TRANSCRIPTION; GENETICS; LIVER CELL; LIVER TUMOR; METABOLISM; MOLECULAR GENETICS; MOUSE; MUTAGENESIS; PHYSIOLOGY; PROMOTER REGION; RAT;

ANIMALS; BASE SEQUENCE; CACO-2 CELLS; CARRIER PROTEINS; DNA-BINDING PROTEINS; ENDODERM; FATTY ACID-BINDING PROTEINS; HEPATOCYTE NUCLEAR FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); RATS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSGENES; TUMOR SUPPRESSOR PROTEINS;

EID: 0038001517     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00074.2003     Document Type: Article

References (70)

1. Akiyama TE, Ward JM, and Gonzalez FJ. Regulation of the liver fatty acid-binding protein gene by hepatocyte nuclear factor 1α (HNF-1α). Alterations in fatty acid homeostasis in HNF-1α-deficient mice. J Biol Chem 275: 27117-27122, 2000.
2. Babajko S and Groyer A. Interplay of the liver-enriched transacting factors, DBP and HNF-1, in the transactivation of human IGFBP-1 promoter. Biochem Biophys Res Commun 196: 480-486, 1993.
3. Bass NM, Manning JA, Ockner RK, Gordon JI, Seetharam S, and Alpers DH. Regulation of the biosynthesis of two distinct fatty acid-binding proteins in rat liver and intestine. Influences of sex difference and of clofibrate. J Biol Chem 260: 1432-1436, 1985.
4. Bielinska M and Wilson DB. Regulation of J6 gene expression by transcription factor GATA-4. Biochem J 307: 183-189, 1995.
5. Boudreau F, Rings EHHM, van Wering HM, Kim RK, Swain GP, Krasinski SD, Moffett J, Grand RJ, Suh ER, and Traber PG. Hepatocyte nuclear factor-1α, GATA-4, and caudal related homeodomain protein Cdx2 interact functiona]]y functionally to modulate intestinal gene transcription. Implication for the developmental regulation of the sucrase-isomaltase gene. J Biol Chem 277: 31909-31917, 2002.
6. Boudreau F, Zhu Y, and Traber PG. Sucrase-isomaltase gene transcription requires the hepatocyte nuclear factor-1 (HNF-1) regulatory element and is regulated by the ratio of HNF-1α to HNF-1β. J Biol Chem 276: 32122-32128, 2001.
7. Byrne NM, Sturis J, Menzel S, Yamagata K, Fajans SS, Dronsfield MJ, Bain SC, Hattersley AT, Velho G, Froguel P, Bell GI, and Polonsky KS. Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12. Diabetes 45: 1503-1510, 1996.
8. Cassuto H, Aran A, Cohen H, Eisenberger CL, and Reshef L. Repression and activation of transcription of phosphoenolpyruvate carboxykinase gene during liver development. FEBS Lett 457: 441-444, 1999.
9. Cha JY, Kim H, Kim KS, Hur MW, and Ahn Y. Identification of transacting factors responsible for the tissue-specific expression of human glucose transporter type 2 isoform gene. Cooperative role of hepatocyte nuclear factors 1α and 3β. J Biol Chem 275: 18358-18365, 2000.
10. Cohn SM, Roth KA, Birkenmeier EH, and Gordon JI. Temporal and spatial patterns of transgene expression in aging adult mice provide insights about the origins, organization, and differentiation of the intestinal epithelium. Proc Natl Acad Sci USA 88: 1034-1038, 1991.
11. 1-antitrypsin promoters. Science 238: 688-692, 1987.
12. Dabeva MD, Hurston E, and Sharitz DA. Transcription factor and liver-specific mRNA expression in facultative epithelial progenitor cells of liver and pancreas. Am J Pathol 147: 1633-1648, 1995.
13. De Simone V, De Magistris L, Lazzaro D, Gerstner J, Monaci P, Nicosia A, and Cortese R. LFB3, a heterodimerforming homeoprotein of the LFB1 family, is expressed in specialized epithelia. EMBO J 10: 1435-1443, 1991.
14. Dogra SC and May BK. Liver-enriched transcription factors, HNF-1, HNF-3, and C/EBP, are major contributors to the strong activity of the chicken CYP2H1 promoter in chick embryo hepatocytes. DNA Cell Biol 16: 1407-1418, 1997.
15. Drewes T, Senkel S, Holewa B, and Ryffel GU. Human hepatocyte nuclear factor 4 isoforms are encoded by distinct and differentially expressed genes. Mol Cell Biol 16: 925-931, 1996.
16. Duncan SA, Navas MA, Dufort D, Rossant J, and Stoffel M. Regulation of a transcription factor network required for differentiation and metabolism. Science 281: 692-695, 1998.
17. Ellard S. Hepatocyte nuclear factor 1 alpha (HNF-1α) mutations in maturity-onset diabetes of the young. Hum Mutat 16: 377-385, 2000.
18. Frayling TM, Evans JC, Bulman MP, Pearson E, Allen L, Owen K, Bingham C, Hannemann M, Shepherd M, Ellard S, and Hattersley AT. β-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes 50: S94-S100, 2001.
19. Froguel P and Velho G. Molecular genetics of maturity-onset diabetes of the young. Trends Endocrinol Metab 10: 142-146, 1999.
20. Hatzis P and Talianidis I. Regulatory mechanisms controlling human hepatocyte nuclear factor 4α gene expression. Mol Cell Biol 21: 7320-7330, 2001.
21. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV, Ignatieva EV, Ananko EA, Podkolodnaya OA, Kolpakov FA, Podkolodny NL, and Kolchanov NA. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 26: 362-367, 1998.
22. Hochman JA, Sciaky D, Whitaker TL, Hawkins JA, and Cohen MB. Hepatocyte nuclear factor-1α regulates transcription of the guanylin gene. Am J Physiol Gastrointest Liver Physiol 273: G833-G841, 1997.
23. 1-antitrypsin gene expression in human intestinal epithelial cell line Caco-2 by HNF-1α and HNF-4. Am J Physiol Gastrointest Liver Physiol 276: G1181-G1194, 1999.
24. Ishii Y, Hansen AJ, and Mackenzie PI. Octamer transcription factor-1 enhances hepatic nuclear factor-1α-mediated activation of the human UDP glucuronosyltransferase 2B7 promoter. Mol Pharmacol 57: 940-947, 2000.
25. Iwasaki N, Oda N, Ogata M, Hara M, Hinokio Y, Oda Y, Yamagata K, Kanematsu S, Ohgawara H, Omori Y, and Bell GI. Mutations in the hepatocyte nuclear factor-1α/MODY3 gene in Japanese subjects with early- and late-onset NIDDM. Diabetes 46: 1504-1508, 1997.
26. Iwasaki N, Ogata M, Tomonaga O, Kuroki H, Kasahara T, Yano N, and Iwamoto Y. Liver and kidney function in Japanese patients with maturity-onset diabetes of the young. Diabetes Care 21: 2144-2148, 1998.
27. Krasinski SD, Van Wering HM, Tannemaat MR, and Grand RJ. Differential activation of intestinal gene promoters: functional interactions between GATA-5 and HNF-1α. Am J Physiol Gastrointest Liver Physiol 281: G69-G84, 2001.
28. Kritis AA, Ktistaki E, Barda D, Zannis VI, and Talianidis I. An indirect negative autoregulatory mechanism involved in hepatocyte nuclear factor-1 gene expression. Nucleic Acids Res 21: 5882-5889, 1993.
29. Ktistaki E and Talianidis I. Modulation of hepatic gene expression by hepatocyte nuclear factor 1. Science 277: 109-112, 1997.
30. Lee SY, Nagy BP, Brooks AR, Wang DM, Paulweber B, and Levy-Wilson B. Members of the caudal family of homeodomain proteins repress transcription from the human apolipoprotein B promoter in intestinal cells. J Biol Chem 271: 707-718, 1996.
31. Lee YH, Sauer B, and Gonzalez FJ. Laron dwarfism and non-insulin-dependent diabetes mellitus in the HNF-1α knockout mouse. Mol Cell Biol 18: 3059-3068, 1998.
32. Legraverend C, Eguchi H, Strom A, Lahuna O, Mode A, Tollet P, Westin S, and Gustafsson JA. Transactivation of the rat CYP2C13 gene promoter involves HNF-1, HNF-3, and members of the orphan receptor subfamily. Biochemistry 33: 9889-9897, 1994.
33. Magee TR, Cai Y, El-Houseini ME, Locker J, and Wan YJ. Retinoic acid mediates down-regulation of the alpha-fetoprotein gene through decreased expression of hepatocyte nuclear factors. J Biol Chem 273: 30024-30032, 1998.
34. Mendel DB, Hansen LP, Graves MK, Conley PB, and Crabtree GR. HNF-1α and HNF-1β (vHNF-1) share dimerization and homeodomains, but not activation domains, and form heterodimers in vitro. Genes Dev 5: 1042-1056, 1991.
35. Menzel R, Kaisaki PJ, Rjasanowski I, Heinke P, Kerner W, and Menzel S. A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1α (HNF-1α) gene. Diabet Med 15: 816-820, 1998.
36. Merika M and Thanos D. Enhanceosomes. Curr Opin Genet Dev 11: 205-208, 2001.
37. Mitchelmore C, Troelsen JT, Sjostrom H, and Noren O . The HOXC11 homeodomain protein interacts with the lactase-phlorizin hydrolase promoter and stimulates HNF-1α-dependent transcription. J Biol Chem 273: 13297-13306, 1998.
38. Mitchelmore C, Troelsen JT, Spodsberg N, Sjostrom H, and Noren O. Interaction between the homeodomain proteins Cdx2 and HNF-1α mediates expression of the lactase-phlorizin hydrolase gene. Biochem J 346: 529-535, 2000.
39. Moore DD, Marks AR, Buckley DI, Kapler G, Payvar F, and Goodman HM. The first intron of the human growth hormone gene contains a binding site for glucocorticoid receptor. Proc Natl Acad Sci USA 82: 699-702, 1985.
40. Owen K and Hattersley AT. Maturity-onset diabetes of the young: from clinical description to molecular genetic characterization. Best Practice Res Clin Endocrinol Metab 15: 309-323, 2001.
41. Pani L, Overdier DG, Porcella A, Qian X, Lai E, and Costa RH. Hepatocyte nuclear factor 3β contains two transcriptional activation domains, one of which is novel and conserved with the Drosophila fork head protein. Mol Cell Biol 12: 3723-3732, 1992.
42. Pare JF, Roy S, Galarneau L, and Belanger L. The mouse fetoprotein transcription factor (FTF) gene promoter is regulated by three GATA elements with tandem E box and Nkx motifs, and FTF in turn activates the HNF-3β, HNF-4α, and HNF-1α gene promoters. J Biol Chem 276: 13136-13144, 2001.
43. Pontoglio M, Barra J, Hadchouel M, Doyen A, Kress C, Bach JP, Babinet C, and Yaniv M. Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell 84: 575-585, 1996.
44. Pontoglio M, Sreenan S, Roe M, Pugh W, Ostrega D, Doyen A, Pick AJ, Baldwin A, Velho G, Froguel P, Levisetti M, Bonner-Weir S, Bell GI, Yaniv M, and Polonsky KS. Defective insulin secretion in hepatocyte nuclear factor 1α-deficient mice. J Clin Invest 101: 2215-2222, 1998.
45. Rey-Campos J, Chouard T, Yaniv M, and Cereghini S. vHNF1 is a homeoprotein that activates transcription and forms heterodimers with HNF1. EMBO J 10: 1445-1457, 1991.
46. Ryffel GU. Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF)1 and HNF4 families: functional and pathological consequences. J Mol Endocrinol 27: 11-29, 2001.
47. Saam JR and Gordon JI. Inducible gene knockouts in the small intestinal and colonic epithelium. J Biol Chem 274: 38071-38082, 1999.
48. Schug J and Overton GC. TESS: Transcription element search software on the www. In: Technical Report CBIL-TR-1997-1001-v0.0: Computational Biology and Informatics Laboratory. Philadelphia, PA: University of Pennsylvania School of Medicine, 1997.
49. Shepherd M, Sparkes A, and Hattersley A. Genetic testing in maturity onset diabetes of the young (MODY): A new challenge for the diabetic clinic. Pract Diab Int 18: 16-21, 2001.
50. Shih DQ, Bussen M, Sehayek E, Ananthanarayanan M, Shneider BL, Suchy FJ, Shefer S, Bollileni JS, Gonzalez FJ, Breslow JL, and Stoffel M. Hepatocyte nuclear factor-1α is an essential regulator of bile acid and plasma cholesterol metabolism. Nat Genet 27: 375-382, 2001.
51. Simon TC, Cho A, Tso P, and Gordon JI. Suppressor and activator functions mediated by a repeated heptad sequence in the liver fatty acid-binding protein gene (Fabpl). Effects on renal, small intestinal, and colonic epithelial cell gene expression in transgenic mice. J Biol Chem 272: 10652-10663, 1997.
52. Simon TC, Roth KA, and Gordon JI. Use of transgenic mice to map cis-acting elements in the liver fatty acid-binding protein gene (Fabpl) that regulate its cell lineage-specific, differentiation-dependent, and spatial patterns of expression in the gut epithelium and in the liver acinus. J Biol Chem 268: 18345-18358, 1993.
53. Sladek FM, Zhong WM, Lai E, and Darnell JE Jr. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev 4: 2353-2365, 1990.
54. Song YH, Ray K, Liebhaber SA, and Cooke NE. Vitamin D-binding protein gene transcription is regulated by the relative abundance of hepatocyte nuclear factors 1α and 1β. J Biol Chem 273: 28408-28418, 1998.
55. Suaud L, Hemimou Y, Formstecher P, and Laine B. Functional study of the E276Q mutant hepatocyte nuclear factor-4α found in type 1 maturity-onset diabetes of the young: impaired synergy with chicken ovalbumin upstream promoter transcription factor II on the hepatocyte nuclear factor-1 promoter. Diabetes 48: 1162-1167, 1999.
56. Sweetser DA, Birkenmeier EH, Hoppe PC, McKeel DW, and Gordon JI. Mechanisms underlying generation of gradients in gene expression within the intestine: an analysis using transgenic mice containing fatty acid binding protein-human growth hormone fusion genes. Genes Dev 2: 1318-1332, 1988.
57. Taylor JK, Boll W, Levy T, Suh E, Siang S, Mantei N, and Traber PG. Comparison of intestinal phospholipase A/lysophospholipase and sucrase-isomaltase genes suggest a common structure for enterocyte-specific promoters. DNA Cell Biol 16: 1419-1428, 1997.
58. Trahair JF, Neutra MR, and Gordon JI. Use of transgenic mice to study the routing of secretory proteins in intestinal epithelial cells: analysis of human growth hormone compartmentalization as a function of cell type and differentiation. J Cell Biol 109: 3231-3242, 1989.
59. Triggs-Raine BL, Kirkpatrick RD, Kelly SL, Norquay LD, Cattini PA, Yamagata K, Hanley AJG, Zinman B, Harris SB, Barrett PH, and Hegele RA. HNF-1α G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community. Proc Natl Acad Sci USA 99: 4614-4619, 2002.
60. Tronche F and Yaniv M. HNF1, a homeoprotein member of the hepatic transcription regulatory network. Bioessays 14: 579-587, 1992.
61. Tsay W, Lee YM, Lee SC, Shen MC, and Chen PJ. Synergistic transactivation of HNF-1α, HNF-3, and NF-I contributes to the activation of the liver-specific protein C gene. DNA Cell Biol 16: 569-577, 1997.
62. Van Wering H, Huibregtse I, van der Zwan S, de Bie M, Dowling L, Grand R, and Krasinski S. Physical interaction between GATA-5 and HNF-1α results in synergistic activation of the human lactase-phlorizin hydrolase promoter. J Biol Chem 277: 27659-27667, 2002.
63. Vaxillaire M, Abderrahmani A, Boutin P, Bailleul B, Froguel P, Yaniv M, and Pontoglio M. Anatomy of a homeoprotein revealed by the analysis of human MODY3 mutations. J Biol Chem 274: 35639-35646, 1999.
64. Vaxillaire M, Rouard M, Yamagata K, Oda N, Kaisaki PJ, Boriraj W, Chevre JC, Boccio V, Cox RD, Lathrop GM, Dussoix P, Philippe J, Timsit J, Charpentier G, Velho G, Bell GI, and Froguel P. Identification of nine novel mutations in the hepatocyte nuclear factor 1 alpha gene associated with maturity-onset diabetes of the young (MODY3). Hum Mol Genet 6: 583-586, 1997.
65. Veitia RA. Exploring the etiology of haploinsufficiency. Bioessays 24: 175-184, 2002.
66. Velho G and Froguel P. Maturity-onset diabetes of the young (MODY), MODY genes and non-insulin-dependent diabetes mellitus. Diabetes Metab 23, Suppl 2: 34-37, 1997.
67. Wu GD, Chen L, Forslund K, and Traber PG. Hepatocyte nuclear factor-1α (HNF-1α) and HNF-1β regulate transcription via two elements in an intestine-specific promoter. J Biol Chem 269: 17080-17085, 1994.
68. Wu KJ, Wilson DR, Shih C, and Darlington GJ. The transcription factor HNF1 acts with C/EBP alpha to synergistically activate the human albumin promoter through a novel domain. J Biol Chem 269: 1177-1182, 1994.
69. Yanuka-Kashles O, Cohen H, Trus M, Aran A, Benvenisty N, and Reshef L. Transcriptional regulation of the phosphoenolpyruvate carboxykinase gene by cooperation between hepatic nuclear factors. Mol Cell Biol 14: 7124-7133, 1994.
70. Zaret K. Developmental competence of the gut endoderm: genetic potentiation by GATA and HNF3/fork head proteins. Dev Biol 209: 1-10, 1999.